Endocrinology, Diabetes & Metabolism Doctors in Toms River, NJ Accepting Medicare

5 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 5

Dr. Joseph A Rodriguez, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1314 Hooper Ave, Suite 3, Toms River, NJ 08753 Phone: 732-244-9989    Fax: 732-341-9920

Miss Paula T Imai, APRN-BC, CDE Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1163 Route 37 W, Suite A-1, Toms River, NJ 08755 Phone: 732-736-1000    Fax: 732-736-8811

Dr. Ahmet Selcuk Can, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 40 Bey Lea Road, Bldg B Suite B202, Toms River, NJ 08753 Phone: 732-341-9965    Fax: 732-341-9588

Dr. David S. Kleinman Iv, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 40 Bey Lea Rd Ste B202, Toms River, NJ 08753 Phone: 732-341-9965    Fax: 732-341-9588

Dr. Leslie Catherine Taguba-madrid, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1163 Route 37 W, Suite A-1, Toms River, NJ 08755 Phone: 732-736-1000    Fax: 732-736-8811

News Archive

New clinical data highlights potential of AB-PA01 to treat P. aeruginosa infections in CF patients

AmpliPhi Biosciences Corporation, a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, presented data at the European Congress of Clinical Microbiology and Infectious Diseases summarizing both the in vitro and in vivo activity of its proprietary, investigational phage mix AB-PA01.

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.

Hemispherx Biopharma awarded grant for Ampligen, Alferon development programs

Hemispherx Biopharma, Inc. announced today grant awards totaling $488,958 from the U.S. Department of Treasury in support of its Ampligen and Alferon development programs.

Senior breast cancer patients receive ‘chemo' if treated in private practices

In a study to determine the non-medical factors that may be associated with the decision to treat nonmetastatic breast cancer, researchers at Columbia University Mailman School of Public Health evaluated the association between oncologist characteristics and the receipt of chemotherapy in elderly women with breast cancer and found that they were more likely to receive chemotherapy if treated by oncologists employed in a private practice.

Read more Medical News

› Verified 7 days ago